ARDS

ARDSnet Protocol
Inclusion

PaO₂/FiO₂ ≤300

Bilateral infiltrates

No clear LA HTN / cardiogenic edema

Oxygenation Goal

PaO₂ 55–80 mmHg

SpO₂ 88–95%

Minimum PEEP 5 cm H₂O

Vent Setup

Start Vt 8 mL/kg PBW

Reduce to 6 mL/kg PBW

Set RR near baseline minute ventilation, max 35

Plateau Goal

Pplat ≤30 cm H₂O

If >30, decrease Vt by 1 mL/kg steps to min 4

If <25 and Vt <6, increase by 1 mL/kg

Lower PEEP / Higher FiO₂
FiO₂ 0.3 0.4 0.4 0.5 0.5 0.6 0.7 0.7 0.7 0.8 0.9 0.9 0.9 1.0
PEEP 5 5 8 8 10 10 10 12 14 14 14 16 18 18–24
Higher PEEP / Lower FiO₂
FiO₂ 0.3 0.3 0.3 0.3 0.3 0.4 0.4 0.5 0.5 0.5–0.8 0.8 0.9 1.0 1.0
PEEP 5 8 10 12 14 14 16 16 18 20 22 22 22 24

Goal Tidal Volume

P/F Ratio

Definitions


  • P/F <300: mild 200–300, moderate 100–200, severe <100
  • PEEP >5
  • Onset <7 days
  • No elevated LVEDP (non-cardiogenic pulmonary edema)
  • Bilateral opacities

Causes


  • PNA
  • Sepsis
  • Pancreatitis
  • Aspiration

Treatment


  • Low TV (6cc/kg): reduces volutrauma
  • Plateau <30: reduces barotrauma
  • High PEEP: recruits alveoli and improved oxygenation
  • Proning: improves V/Q mismatching, mortality benefit if P/F <150
  • Paralytics: atracurium, short course if severer dyssynchrony or refractory hypoxemia
  • VV ECMO: used for refractory hypoxemia despite optimal vent settings (P/F <80-100)

Trials


  • ACURASYS → early paralysis improved oxygenation, unclear mortality benefit
  • PROSEVA → proning ≥16h/day ↓ mortality in severe ARDS (P/F <150)

PROSEVA Trial

28-day mortality in severe ARDS

Prone: 16.0% vs Supine: 32.8%